MARCH Outcome Evaluation
As shown in Table 12, the perceived efficacy and positive outcome expectancy in relation to HIV testing were positively and significantly correlated with exposure to the MARCH intervention. As can be seen, the median self-efficacy score increased from 3.9 among the non-exposed, to levels of 4.0 and 4.4 among the moderately-and highly-exposed, respectively. Likewise, the corresponding proportion of respondents that scored above the median in the HIV testing self-efficacy score (i.e. high self-efficacy level) ranged from 34.4% to 49% and 59.5% (p<0.01), respectively.
The median score for the positive outcome expectancy was 3.6 for the non-exposed respondents. This figure, however, was significantly lower than the mean scores of 3.9 and 3.8, respectively, recorded for the moderately-and highly-exposed respondents. Similarly, the proportion of respondents who scored above the median in the positive outcome expectancy scale also showed significant association with exposure to the MARCH. While about 50.1% of the non-exposed demonstrated high positive outcome expectancy in relation to HIV testing, the corresponding proportions for the moderately-and highly-exposed respondents were 61.3% and 62.1%, respectively. Of note, the grossly observed significant association between these psychosocial scales and exposure to the MARCH in the univariate analysis did not alter in the multivariate analyses after adjusting for sex, age, educational status and marital status of respondents (Table 13). The odds of exhibiting high perception of self-efficacy in relation to HIV testing was 1.6 and 2.4 times higher, respectively, for the moderately-and highly-exposed respondents as compared to the non-exposed. Likewise, the corresponding odds for HIV testing outcome expectancy were found to be 1.7 and 1.9 time higher, respectively.
Addis Ababa and West Hararghe